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BACKGROUND: To help oncologists and breast cancer patients make informed
decisions about adjuvant therapies, online tools such as Adjuvant! provide tai-
lored estimates of mortality and recurrence risks. However, the graphical format
used to display these results (a set of 4 horizontal stacked bars) may be subopti-
mal. The authors tested whether using simpler formats would improve compre-
hension of the relevant risk statistics.
METHODS: A total of 1619 women, aged 40-74 years, completed an Internet-admi-
nistered survey vignette about adjuvant therapy decisions for a patient with an
estrogen receptor-positive tumor. Participants were randomized to view 1 of 4
risk graphics, a base version that mirrored the Adjuvant! format, an alternate
graph that showed only 2 options (those that included hormonal therapy), a
graph that used a pictograph format, or a graph that included both changes. Out-
come measures included comprehension of key statistics, time required to com-
plete the task, and graph-perception ratings.
RESULTS: The simplifying format changes significantly improved comprehension,
especially when both changes were implemented together. Compared with parti-
cipants who viewed the base 4-option bar graph, respondents who, instead,
viewed a 2-option pictograph version were more accurate when they reported
the incremental risk reduction achievable from adding chemotherapy to hormo-
nal therapy (77% vs 51%; P<.001), answered that question more quickly (median
time, 28 seconds vs 42 seconds; P<.001), and liked the graph more (mean, 7.67
vs 6.88; P<.001).
CONCLUSIONS: Although most patients will only view risk calculators such as Ad-
juvant! in consultation with their clinicians, simplifying design graphics could
significantly improve patients’ comprehension of statistics essential for informed
decision making about adjuvant therapies. Cancer 2008;113:3382–90. Published
2008 by the American Cancer Society.*
KEYWORDS: decision aids, risk, patient education, audiovisual aids.
O ne of the most difficult decisions faced by postoperative breastcancer patients concerns whether, and in what form, to take ad-
juvant therapy to reduce the likelihood of cancer recurrence. This
decision involves a tradeoff between the risk reduction achievable
by chemotherapy (which is a function of tumor and patient charac-
teristics) and the morbidity associated with these treatments. For
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patients with estrogen receptor-positive tumors, hor-
monal therapy is an additional option used either
singly or in conjunction with chemotherapy agents.
Patients’ preferences, specifically the relative value
the patient places on reducing the risk of recurrence
versus treatment burden, directly influence which
choice is optimal.1-3
To help guide decisions about adjuvant thera-
pies, many clinicians use online tools to calculate
tailored estimates of mortality risks, recurrence risks,
and potential benefits of each therapy option. These
estimates are based on complex algorithms that
account for (at a minimum) tumor size, grade, and
estrogen receptor status, lymph node status, patient
age, and patient health status. One of the most com-
monly used tools, Adjuvant! Version 8 (www.adju-
vantonline.com),2-4 presents this information to
clinicians (and to patients by means of printable
handouts) in a complex graphical format similar to
that shown in Figure 1. The graph uses horizontal
bars to represent 10-year outcomes for each of 4
possible options as follows: no adjuvant therapy,
hormonal therapy only, chemotherapy only, and
both chemotherapy and hormonal therapy. The no
therapy bar describes how many women out of 100
would be alive (green section), dead because of
breast cancer (red section), or dead because of other
causes (blue section) in 10 years. The remaining
bars repeat this information but also show how the
number of women alive would increase with the use
of each adjuvant therapy (compared with no ther-
apy) in yellow.
Although this format presents a complete picture
of the risks and benefits associated with the adjuvant
therapy decision, the risk-communication literature
suggests that this graphical format may be subopti-
mal, inhibiting accurate comprehension of relevant
information. Several studies have shown that hori-
zontal bars are more difficult to comprehend than
alternate formats like pictographs (sometimes called
icon arrays or image matrices).5-10 In addition, the
standard Adjuvant! format always displays informa-
tion about 3 treatment options, each compared with
a no therapy option, although in most cases the
therapeutic decision is only between 2 options (eg,
between hormonal therapy only vs combined therapy
when the patient is estrogen receptor-positive or
between chemotherapy and no therapy when the
patient is estrogen receptor-negative). Such extrane-
ous information increases the cognitive effort
required to interpret the graph, which may, therefore,
result in reduced understanding.11-13
Risk calculators such as Adjuvant! are designed
for use by clinicians, and practicing oncologists are
undoubtedly able to correctly interpret the complex
graphic with regular exposure. However, many clini-
cians use Adjuvant! as a tool to facilitate discussion
of adjuvant therapy options with their patients, ei-
ther by presenting and discussing the patient hand-
out or by going online with the patient during a
consultation. Because patients lack specific experi-
ence with the Adjuvant! tool, their understanding of
the risk information may be inhibited by the com-
plexity of the graph.14 If so, patients’ misinterpreta-
FIGURE 1. Shown is the baseline risk graphic based on the 4-option horizontal bar format used by Adjuvant!.
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tions of the risk statistics could bias their subsequent
adjuvant therapy decisions.
In this study, we tested whether presenting the
possible outcomes of different adjuvant therapy
options in alternate formats would improve compre-
hension of relevant risk statistics as compared to pre-
senting the same information in the format currently
used in the Adjuvant! tool. We used a randomized ex-
perimental design to systematically vary how the
risks and benefits of adjuvant therapy options were
displayed in a short hypothetical vignette presented
to a demographically diverse population of middle-
aged and older women participating in an Internet-
administered survey. This methodology holds con-
stant the specific risk numbers being displayed. It
thus allows direct identification of the effect of differ-
ent graphical formats without us having to adjust for
the variation in prognoses associated with actual
cancer patients’ diverse tumor characteristics. It also
narrows the field of possible graphical formats to a
specific recommended format which can be vali-
dated in future research using a patient population.
MATERIALS AND METHODS
Overview of Study Design
Each participant was asked to imagine being diag-
nosed with breast cancer after a routine mammo-
gram. The scenario described surgical removal of the
tumor and then presented different options for adju-
vant therapy. We randomly varied the format of the
graph used to present the mortality risks associated
with different adjuvant treatment options and then
assessed participants’ knowledge of the risk statistics
and their preference ratings for the graph type
shown. In addition, to measure ease of use, we elec-
tronically timed how long participants spent on a
key knowledge question. This design received institu-
tional review board exempt-from-approval status, as
the design was anonymous survey research.
Participants
Study participants were women aged 40-74 years
who were drawn from a panel of Internet users
administered by Survey Sampling International (SSI)
and who voluntarily agreed to receive invitations to
fill out questionnaires. E-mail invitations were sent
to a stratified random sample of panel members
with the goal of approximating the US census on
education level, race, and income in the final subject
pool. To ensure at least moderate demographic diver-
sity (but not representativeness) and to offset large
expected variations in response rates (especially for
African Americans and Hispanic Americans), we
established target response levels roughly matching
the prevalence of these racial and/or ethnic groups
in the US population. We also drew 3 distinct age
samples within each race (one-third each aged 40-
49 years, 50-59 years, and 60-74 years) to offset dif-
ferential response rates across age groups. The num-
ber of E-mail invitations in each demographic
subsample was dynamically adjusted until all quotas
were achieved, such as requiring at least 180 com-
pleted surveys from both the African American and
Hispanic American subgroups. Upon their comple-
tion of the survey, participants were entered into
both an instant contest and a monthly drawing for
modest cash prizes administered by SSI.
Intervention
In our scenario, the respondent was asked to imagine
going for a routine mammogram, finding a lump,
having a biopsy, and being diagnosed with breast
cancer. Respondents were then told that the tumor
was removed by surgery (although it was undefined
whether the surgery was breast conserving or a mas-
tectomy) and told that the tumor tested as estrogen
receptor-positive (but no other tumor characteris-
tics). The scenario then described the physician as
making a strong recommendation that the patient
take hormonal therapy but leaving up to the patient
the question up of whether or not to also take chem-
otherapy. Respondents then viewed the target gra-
phic along with explanatory text.
To create the graphs, we used mortality risk sta-
tistics derived from Adjuvant! for a 59-year-old
patient in good health with a 2.5 cm grade 3 estrogen
receptor-positive tumor but without lymph node
involvement. All study participants received identical
risk information. We used a randomized experimen-
tal design (subjects were randomly assigned by com-
puter to 1 of 4 experimental conditions) to compare
the format used in Adjuvant! (Fig. 1) versus 3 alterna-
tive graphs that varied either the format used to dis-
play the risk statistics, the number of adjuvant
therapy options shown, or both.
Graph format
Our base graph (Fig. 1) replicated the horizontal
stacked bar format used in standard Adjuvant!, with
similar layout, proportions, colors, and legend text as
printed on the Adjuvant! handout page for patients.
Our alternative pictograph format used 10 3 10 matri-
ces of small rectangles to represent possible outcomes.
(See tools.cbdsm.org for examples.) The graphic
included 4 pictographs, 1 for each treatment option,
arranged with the no therapy graph on the left and
the 3 adjuvant therapy options to the right. Overall
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image size was approximately the same as the bar for-
mat, and the same color scheme was used to repre-
sent outcomes. Consistent with our previous work on
the communication of incremental risks,7 however, we
modified the legend text to read, ‘‘X percent more
women of 100 are alive because of therapy.’’
Number of options shown
In addition to the 4-option bar graph and picto-
graphs described above, we also created 2 simpler
graphs, one in each format, that only displayed 2
bars or pictographs rather than 4. Because the physi-
cian in our scenario strongly recommended hormo-
nal therapy, the 2 critical options that respondents
needed to consider were hormonal therapy only and
combined therapy. In the simpler 2-option graphs,
only those 2 options were displayed. In addition,
because the no therapy option was omitted, the
entire chance of remaining alive was now colored
green in the hormonal therapy bar or pictograph,
and the yellow incremental benefit area on the com-
bined therapy graph was recalculated to show the
marginal increase in survival versus hormonal ther-
apy (instead of vs no therapy). Doing so clarified the
pragmatic meaning of the graph by removing extra-
neous information11 and displayed the incremental
benefit in a format that is more easily interpreted
using basic graphical perception tasks.15 The 2-
option pictograph image, which illustrates both
manipulations, is shown in Figure 2.
Outcome Measures
Our primary outcome measures were 3 questions
that assessed respondents’ ability to accurately report
key statistics relevant to the adjuvant chemotherapy
decision as follows: the chance that the respondent
would be alive in 10 years with hormonal therapy
only, the chance the respondent would be alive with
both chemotherapy and hormonal therapy, and how
many fewer women out of 100 would die from can-
cer if they received both chemotherapy and hormo-
nal therapy instead of hormonal therapy only.
Because exact numerical information sufficient to
calculate these answers was provided in the graph
legends, responses were only coded as accurate
when they were exactly correct.
We also gathered data on 2 secondary outcome
measures. First, as a measure of the cognitive infor-
mation processing required to interpret the graphs,16
we electronically recorded the number of seconds
that the respondent took to answer the risk differ-
ence question, which was on a separate page from
FIGURE 2. This simplified risk graphic uses a 2-option pictograph format.
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all other questions. Second, we asked respondents to
provide 3 perception ratings about the graph they
saw. Answering each question on a 10-point scale,
respondents rated how well the graph described the
benefits of different additional treatments, whether
the respondent would prefer to see risk information
in this type of graph, and how clearly the graphs rep-
resented the increase in the chance of being alive.
Covariates
Individuals vary in terms of their numeracy, ie, their
facility and comfort with quantitative health informa-
tion such as risk statistics. To assess this important
covariate, study participants completed the Subjec-
tive Numeracy Scale (SNS),17,18 a validated measure
of quantitative ability and of preferences for receiv-
ing information in numerical form. The SNS com-
prises 8 questions, 4 assessing perceived numerical
ability (eg, ‘‘How good are you at calculating a 15%
tip?’’) and 4 assessing preferences for quantitative in-
formation (eg, ‘‘How often do you find numerical in-
formation to be useful?’’). SNS scores range from 1
(least numerate) to 6 (most numerate). The SNS has
previously been shown to correlate with the ability to
recall and comprehend risk communications in both
textual and graphical formats.18
In addition, participants completed demographic
measures including level of education. For analysis
purposes, we modeled education as a 3-level variable
as follows: high school (HS) or less, some post-HS
education but no Bachelor’s degree, and Bachelor’s
degree or more.
Hypotheses
On the basis of prior research that used pictographs,5-10
we expected that this format would facilitate study par-
ticipants’ efforts to comprehend the risk information
provided. Thus, we predicted that women who were
shown risk information in pictograph form would be
both more accurate on the comprehension questions
and quicker to complete the accuracy tasks than
women shown the horizontal bar format. Because of
these advantages, we also hypothesized that respon-
dents would rate pictographs as a more preferred for-
mat than horizontal bar graphs.
Our simpler, 2-option graphs eliminated nones-
sential information and reframed the incremental
benefit to make comparing hormonal therapy only
with combined therapy easier. Because these changes
facilitate direct comprehension of the risk tradeoff
between hormonal therapy and combined therapy,19-21
we hypothesized that respondents who received 2-
option graphs would also have increased compre-
hension accuracy, faster task completion times, and
higher graph preference ratings than respondents
who viewed 4-outcome graphs.
Statistical Analysis
We used chi-square tests of proportions to test
whether the format of a graph affected comprehen-
sion of risk statistics, Student t tests to compare
graph preference ratings, and Wilcoxon rank-sum
tests (to compensate for highly skewed distributions)
to compare the distributions of time spent answering
the knowledge question on the marginal benefit of
treatment. We also used a logistic regression analysis
to assess whether participants’ comprehension of dif-
ferent graphs was mediated by numeracy. All analy-
ses were performed by using STATA 10,22 and all
tests of significance were 2-sided and used a 5 .05.
RESULTS
A total of 2251 individuals reached the survey website
and viewed the first content page. Of these, 603 (27%)
failed to complete the survey. In addition, 5 were
excluded for completing the survey too quickly to
have paid attention, 16 were male and hence excluded,
and 8 were excluded for reporting ages outside of the
requested sample range. (See Fig. 3 for details of par-
ticipant flow through the survey instrument.) Comple-
tion rates did not differ significantly across the 4 arms
of our randomized controlled trial design. Our analy-
ses focus on the remaining 1619 participants.
Sample demographic characteristics are described
in Table 1. We observed a wide range of educational
FIGURE 3. The flow of this study is depicted.
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achievement, with 27% of participants having com-
pleted a Bachelor’s or higher college degree but also
25% with only a high school education or less. While
23% of respondents reported having had a prior
breast biopsy, 4% had a prior diagnosis of breast can-
cer, and 19% reported having a first-degree relative
with a prior diagnosis of breast cancer, a sensitivity
analysis showed that exclusion of these groups did
not qualitatively change the results reported below.
As expected given our experimental design, there
were no significant variations in sample demo-
graphics across experimental conditions.
Comprehension of Risk Statistics
Because our scenario described a patient with an
estrogen receptor-positive tumor, our first 2 compre-
hension questions assessed participants’ ability to
report the total chance of being alive in 10 years if
the patient took hormonal therapy only or if she
took both chemotherapy and hormonal therapy. The
results are shown in Table 2. The accuracy rates
among participants viewing the base 4-option bar
graph were strikingly low; approximately 17% of
respondents answered each question correctly. How-
ever, significantly improved accuracy was observed
with each of our alternative graphs, especially the 2-
option pictograph.
Perhaps the most critical information related to
the adjuvant therapy decision presented in our sce-
nario is the difference between these 2 numbers, ie,
the incremental risk reduction achieved by adding
adjuvant chemotherapy to hormonal therapy. The
percentage of respondents correctly noting that 2
fewer women out of 100 would die if they took
chemotherapy in addition to hormonal therapy is
shown in Figure 4. Although respondents who viewed
4-option graphs (whether bar or pictograph) were
only able to correctly answer this question about half
of the time, accuracy was significantly improved
among participants who were shown the 2-option
bar graph [v2(1) 5 14.95; P<.001] and again espe-
cially among those who viewed the 2-option picto-
graph [v2(1) 5 57.23; P<.001].
A logistic regression analysis (Table 3) showed
that these format effects remain highly significant af-
ter we controlled for both a strong and statistically
significant effect of individual numeracy as well as a
weaker independent effect of education. All race, eth-
nicity, and breast cancer experience variables were
nonsignificant predictors of comprehension. An
expanded model (not shown) showed no significant
interactions between numeracy and any of the graph
formats. As a result, respondents who saw 2-option
pictographs had higher comprehension rates than
those who viewed 4-option bar graphs, regardless of
TABLE 1
Sample Characteristics
Continuous Characteristic Mean [SD]/Median
Age, y 54.5 [8.6]/54
Subjective Numeracy Score, 1-6 4.14 [1.13]/4.38




Other/mixed race 283 (17.6)
Hispanic ethnicity, any race 178 (11.1)
Education
£High school diploma 404 (25.0)
Some college 779 (48.2)
‡Bachelor’s degree 434 (26.8)
Prior breast cancer experience
Prior breast biopsy 365 (22.6)
Prior breast cancer diagnosis 69 (4.3)
First-degree relative with breast cancer 313 (19.4)
SD indicates standard deviation from the mean.
TABLE 2
Proportion of Respondents Correctly Reporting Total Survival Rates by Graph Type
Question
4-Option Graph 2-Option Graph
Horizontal Bar Pictograph Horizontal Bar Pictograph
(1) (2) (3) (4)
Total no. alive with hormonal therapy only 69/393 (17.6%) 130/389 (33.4%) 267/405 (65.9%) 234/364 (64.3%)
v2 test (1 df) vs Column 1 — 25.93* 191.43* 171.89*
Total # Alive with Combined Therapy 67/401 (16.7%) 128/405 (31.6%) 153/410 (37.3%) 188/378 (49.7%)
v2 test (1 df) vs Column 1 — 24.38* 43.56* 96.39*
*Significant at P<.001
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whether they scored above median on the Subjective
Numeracy Scale (2-option pictograph, 85.3% vs 4-
option bar, 62.4%) or below median (2-option picto-
graph, 69.0% vs 4-option bar, 43.1%).
Timing Data
The median time spent completing the risk-differ-
ence question, which was asked on a separate web
page from the rest of the survey, is shown in Figure
5. Presenting all 4 treatment options in a pictograph
instead of the base horizontal bar format had no
effect on time spent. However, Wilcoxon rank-sum
tests showed that respondents who viewed simplified
images that only presented information about 2
options were able to complete the question in signif-
icantly less time (bar, z 5 4.69; pictograph, z 5 7.89;
both P<.001), with the shortest median time (28 sec-
onds) observed in the group who received the 2-
option pictographs. In addition, among respondents
who viewed the 2-option graphs (but not among
respondents who viewed 4-option graphs), knowl-
edge accuracy was significantly higher among parti-
cipants who completed the task in 30 seconds or less
(bar, 78.2%; pictograph, 84.0%) compared with parti-
cipants who took more than 30 seconds to complete
the task [bar, 54.0%, v2(1) 5 25.82, P<.001; picto-
graph, 68.6%, v2(1) 5 12.53, P<.001].
Ratings of Different Formats
Participants ratings on the 3 graph-perception ques-
tions were highly correlated, so we combined all 3
questions into a single scale with very high reliability
(a 5 .91). The 4-option and the 2-option pictograph
graphics received the highest scores (mean 5 7.68 &
7.67, respectively), significantly higher than those for
the base 4-option bar graph (mean 5 6.88; Student t
5 4.62 vs 4-option pictograph; Student t 5 4.43 vs 2-
option pictograph; both P<.001). The 2-option bar
graph was also significantly preferred to the 4-option
base graphic, although the effect was not as large
(mean 5 7.33 vs 6.88; Student t 5 2.49; P 5 .01).
DISCUSSION
Whereas decision support tools such as Adjuvant!
use graphical displays to communicate the mortality
risks that patients face with different adjuvant ther-
apy options, our research shows that women had
difficulty interpreting the 4-option horizontal bar for-
mat currently used by Adjuvant!. Two simple
changes, displaying only risk information related to
treatment options that included hormonal therapy
TABLE 3
Logistic Regression Analysis of Respondents’ Comprehension of the
Risk Reduction due to Addition of Chemotherapy to
Hormonal Therapy
Variable
Comprehension of Benefit of Adding
Chemotherapy to Hormonal Therapy
Odds Ratio 95% CI z-Statistic
4-Option pictograph vs base 1.06 0.79, 1.42 0.37
2-Option bar vs base 1.72 1.27, 2.32 3.53*
2-Option pictograph vs base 3.27 2.36, 4.54 7.08*
Numeracy, 1-6 1.65 1.48, 1.83 9.37*
Education, 1-3 1.26 1.07, 1.48 2.84y
African-American vs Caucasian 0.71 0.41, 1.25 21.19
Other/Mixed Race vs Caucasian 0.92 0.57, 1.48 20.35
Hispanic ethnicity 0.86 0.60, 1.24 20.81
Age per 10 y 1.02 0.89, 1.16 0.25
Prior breast biopsy 1.27 0.95, 1.70 1.63
Prior breast cancer diagnosis 0.77 0.42, 1.40 20.87
Close relative with breast cancer 0.88 0.67, 1.16 20.93




FIGURE 5. Median time to complete the risk reduction question is shown.FIGURE 4. Comprehension of the risk reduction due to addition of chemo-
therapy to hormonal therapy is illustrated.
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(because the scenario described an estrogen recep-
tor-positive tumor) and using pictographs instead of
horizontal bars, resulted in significant improvements
in both comprehension accuracy and speed of use in
our demographically diverse sample. Furthermore,
respondents showed strong preferences for picto-
graph formats over the currently used horizontal bar
format. It is important to note, however, that sizeable
knowledge deficits were still observed even when risk
information was presented in the best format tested
in this study, the 2-option pictograph. Further
research is clearly needed to explore even more sim-
plified formats to determine whether we can further
improve patient understanding of the risk tradeoffs
associated with adjuvant therapy decisions.
We draw particular attention to the finding that
the participants who viewed the 2-option pictographs
not only took the least amount of time to complete
knowledge tasks (Fig. 5) but also had the lowest error
rates (Fig. 4). Together, these data demonstrate that
reading and interpreting the 2-option pictographs
required less cognitive effort than the 4-option bar
graphs. The task of making complex treatment deci-
sions is both cognitively demanding and emotionally
stressful, and evidence suggests that decision-making
performance is often degraded under such condi-
tions.23,24 Moreover, studies have shown that cogni-
tive effort induces negative emotions in many people
and that these emotions can cause them to withdraw
from making decisions.25 Thus, even if patients could
figure out more complex graphics given time and
support from their clinicians, their ability to use this
information to make their decisions would be
impeded by the cognitive effort required to obtain it.
The use of simpler graphical formats may help to
offset this unwanted effect.26,27
Although individual numeracy levels were
strongly predictive of risk knowledge, the design of
the risk graphic affected both high numerate and low
numerate individuals similarly. Such findings rein-
force our belief that optimal design of risk graphics
is essential for all users, not just for those less edu-
cated or less numerate.
Our research has several limitations. First,
although our Internet sample contained substantial
demographic diversity, we did experience some sig-
nificant dropout during the survey. Those individuals
who failed to complete the survey (and hence did
not provide comparable demographic information)
may have had different characteristics from those
who completed it. Our participants may also be non-
representative in unidentified ways (for example,
because they enjoy taking surveys). However, we
ensured internal validity by using an experimental
design. Furthermore, our previous research using this
panel has shown that Internet survey responses from
this panel closely match those of representative sam-
ples.28 Second, most participants (75%) reported hav-
ing had at least some education beyond high school,
a trait which may limit our ability to generalize these
findings to a less educated population. Third, our
scenario was entirely hypothetical, and actual cancer
patients may be more motivated to correctly inter-
pret risk graphics presented to them by clinicians.
Patients also have the opportunity to discuss such
graphs in face-to-face consultations with their
oncologist, which undoubtedly leads to better com-
prehension than we observed. Nevertheless, our ex-
perimental results suggest that the use of nonoptimal
risk-communication graphics can significantly inhibit
comprehension of key statistics, whereas simpler gra-
phics may enable clinicians to spend less time
explaining risk information to patients and more time
discussing its implications for each patient’s adjuvant
therapy decision.
The results presented here support the concept
that simpler information displays can make it easier
for decision makers to implement optimal decision
strategies.23 Specifically, focusing patients’ attention
on those treatment options currently under consid-
eration while removing information related to
options that have been already eliminated from con-
sideration (for medically appropriate reasons) may
be particularly beneficial.25,29,30 In the context of ad-
juvant therapy decisions, such an approach would
suggest that clinicians should discuss the decision in
2 stages as follows: a first stage in which hormonal
therapy is considered and a second stage in which
the incremental benefit of chemotherapy is evalu-
ated. The 2-option pictograph tested here would be
highly appropriate for the second stage of this dis-
cussion, and a similar graphic showing outcomes for
no therapy versus hormonal therapy could be used
to improve patient comprehension during the first
stage of discussion.
Adjuvant! and other online risk calculators
enable oncologists and patients to receive individu-
ally tailored estimates of mortality and recurrence
risks, information that is essential to making
informed decisions about adjuvant therapy options.
Yet, the full potential of these modeling applications
cannot be realized if users misinterpret the statistics
provided.14 Our results show that certain graphical
formats can preclude patient comprehension. Clini-
cians may face similar difficulties when considering
statistics presented in these formats for clinical deci-
sion making. Developers of risk-communication and
decision-support tools should incorporate evidence-
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based, simplifying design elements, such as removal
of information not required for the current decision
and the use of pictograph formats, into both existing
and future tools.
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